Agarose Bead Technologies expands facility to meet rising global demand for novel therapie... 22/10/2024 Communication Corporate Agarose Bead Technologies has enhanced its Burgos facility by boosting its agarose resin production to 100,000 liters... Partners - Agarose Bead Technologies (ABT)
#NewAseBioMember | “AseBio, for our small biotech, is a platform that offers a multitude o... 12/09/2024 Corporate Meet Telomere Therapeutics, our new member. We spoke with Ana Margarita Maldonado, CMC & Regulatory Manager. AseBio - TELOMERE THERAPEUTICS
#NuevoSocioAseBio | “AseBio es el lugar perfecto para conectar con posibles colaboradores” 03/09/2024 Corporate Meet Duponte, our new member. We spoke with Yolima Puentes, CEO. AseBio - DUPONTE INVESTIGACIÓN Y DESARROLLO S.L.
Mats Sundgren, a distinguished expert in Health Data Strategy, joins IOMED as Scientific A... 06/08/2024 Talento Corporate Mats brings over 37 years of experience in the pharmaceutical industry, with a career marked by significant... Partners - IOMED Medical Solutions SL
#NewAseBioMember | “AseBio is a crucial platform that allows us to connect with other lead... 10/07/2024 Corporate Meet Conoce a Watson Marlow, our new member. We spoke with Jaume Tarragó, Iberia General Director. AseBio - WATSON-MARLOW
How PLG’s insourcing model help support clients? 04/07/2024 Corporate PLG is diverse and growing, with many resources in different countries to expand our support to clients in new ways... Partners - ProductLife Group
Aporta revolutionizes flexible remuneration with its new digital platform 03/07/2024 Corporate The new Aporta platform is distinguished by offering a complete and personalized solution for flexible remuneration... Other/sector
Biobide at the 51st Annual Meeting of the Japanese Society of Toxicology 02/07/2024 Healthcare Climate change Agrifood Industrial biotechnology International Corporate Don't miss us at the 51st Annual Meeting of the Japanese Society of Toxicology! Partners - Biotechnology Assets
ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders 28/06/2024 Corporate All resolutions were approved. Additional resolution to increase capital for up to 100 million euros approved. 42.6867%... Partners - Oryzon Genomics
#NewAseBioMember | “AseBio constitutes a meeting point and driving force for the main acto... 27/06/2024 Corporate Meet Lifesome Therapeutics, our new member. We talked its Diego Pazos Castro, Cancer & Microbiology Research Scientist. AseBio - LIFESOME THERAPEUTICS
